rs12152416; Bipolar disorder; bipolar disorder
rs17061182; Multiple complex diseases; Null
rs812964; Multiple complex diseases; Null
rs780358; Multiple complex diseases; Null
rs517711; Personality dimensions; personality disorder
rs780346; Personality dimensions; personality disorder
rs780347; Personality dimensions; personality disorder
rs673870; Personality dimensions; personality disorder
rs17361780; Multiple complex diseases; Null
rs780354; Gamma gluatamyl transferase levels (interaction with age); alcohol abuse|liver disease
rs780354; Response to taxane treatment (placlitaxel); lung cancer
rs2629877; Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption); hypertension
rs2171077; Nonsyndromic striae distensae (stretch marks); skin disease
rs2605441; Nonsyndromic striae distensae (stretch marks); skin disease
rs2629899; Nonsyndromic striae distensae (stretch marks); skin disease
rs1079196; Personality dimensions; personality disorder
rs1079196; Nonsyndromic striae distensae (stretch marks); skin disease
rs4679614; Personality dimensions; personality disorder
rs4679615; Personality dimensions; personality disorder
rs689497; Alzheimer's disease; Alzheimer's disease
rs17061239; Smoking initiation; nicotine dependence
rs1872495; Personality dimensions; personality disorder
rs10428174; Cleft lip; cleft lip
rs10428174; Personality dimensions; personality disorder
rs639244; Multiple complex diseases; Null
rs598678; Personality dimensions; personality disorder
rs620113; Insulin resistance; type 2 diabetes mellitus
rs11915344; Multiple complex diseases; Null
rs11715245; Alzheimer's disease (late onset); Alzheimer's disease
rs11715245; Serum albumin level; kidney disease|liver disease|cardiovascular system disease
rs294459; Osteoarthritis (knee and hip); osteoarthritis
rs294457; Hepatitis B vaccine response; hepatitis B
rs294454; Waist Circumference; obesity
rs294453; Aortic root size; cardiovascular system disease
rs1825630; Aortic root size; cardiovascular system disease
rs1038516; Multiple complex diseases; Null
rs4502542; Response to citalopram treatment; major depressive disorder
rs17302202; Type 2 diabetes; type 2 diabetes mellitus
rs17061517; Major depressive disorder; major depressive disorder
rs931317; Nicotine smoking; nicotine dependence
rs931317; Myopia (pathological); myopia
rs11707783; Orofacial clefts; orofacial cleft
rs9863289; Aortic root size; cardiovascular system disease
rs212034; Orofacial clefts; orofacial cleft
rs802775; Amyotrophic Lateral Sclerosis; amyotrophic lateral sclerosis
rs2630190; Urinary metabolites; kidney disease
rs2630167; Aortic root size; cardiovascular system disease
rs3772503; Body Composition; obesity|heart disease
rs212016; Orofacial clefts; orofacial cleft
rs212016; Tuberculosis with late age of onset; tuberculosis
rs13086424; Tuberculosis with late age of onset; tuberculosis
rs212017; Alzheimer's disease; Alzheimer's disease
rs212018; Alzheimer's disease; Alzheimer's disease
rs9311744; Aortic root size; cardiovascular system disease
rs802777; Alzheimer's disease; Alzheimer's disease
rs802779; Alzheimer's disease; Alzheimer's disease
rs17061792; Blood Pressure; hypertension
rs3845970; Lipoproteins; lipid metabolism disorder|cardiovascular system disease|obesity
rs3845971; Type 2 diabetes; type 2 diabetes mellitus
rs9311745; Pit-and-Fissure caries; dental caries
rs3912494; Schizophrenia; schizophrenia
rs9817995; Multiple complex diseases; Null
rs9874888; Multiple complex diseases; Null
rs9874888; Narcolepsy; narcolepsy
rs2630161; Type 2 diabetes; type 2 diabetes mellitus
rs182418; Urinary metabolites; kidney disease
rs212063; Type 2 diabetes; type 2 diabetes mellitus
rs212062; Type 2 diabetes; type 2 diabetes mellitus
rs212062; Myocardial Infarction; myocardial infarction
rs212059; Urinary metabolites; kidney disease
rs17257269; Narcolepsy; narcolepsy
rs17257269; Bipolar disorder and schizophrenia; bipolar disorder|schizophrenia
rs3845972; Bone mineral density (BMD), in women; bone resorption disease
rs3856662; Bipolar disorder and schizophrenia; bipolar disorder|schizophrenia
rs212057; Type 2 diabetes; type 2 diabetes mellitus
rs212051; Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption); hypertension
rs212049; Coronary heart disease; coronary artery disease
rs212046; Body Mass Index; obesity
rs212041; Suicide attempts in bipolar disorder; bipolar disorder
rs212039; Suicide attempts in bipolar disorder; bipolar disorder
rs9860107; Endometriosis; endometriosis
rs9860107; Erythrocyte counts; hematopoietic system disease|heart disease
rs7638558; Primary sclerosing cholangitis; sclerosing cholangitis
rs2630165; Type 2 diabetes; type 2 diabetes mellitus
rs2630194; Urinary metabolites; kidney disease
rs2630197; Type 2 diabetes; type 2 diabetes mellitus
rs2630200; Type 2 diabetes; type 2 diabetes mellitus
rs2736821; Type 2 diabetes; type 2 diabetes mellitus
rs17062101; Bipolar disorder and schizophrenia; bipolar disorder|schizophrenia
rs6446109; Multiple complex diseases; Null
rs6772047; Urinary metabolites; kidney disease
rs6766789; Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption); hypertension
rs4679636; Coronary Artery Disease; coronary artery disease
rs4679636; Recombination rate; Null
rs722070; Cytomegalovirus antibody response; viral pneumonia
rs41355450; Parkinson's disease; Parkinson's disease
rs10510828; Longevity; Null
rs10510829; Adverse response to lamotrigine and phenytoin; skin disease|hypersensitivity reaction disease
rs2064020; Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption); hypertension
rs9876685; Multiple sclerosis (OCB status); multiple sclerosis
rs1566057; Body mass index; obesity
rs213307; Amyotrophic Lateral Sclerosis; amyotrophic lateral sclerosis
rs11130760; Oral cancers (chewing tobacco related); squamous cell carcinoma|mouth disease
rs11717164; Tuberculosis with early age of onset; tuberculosis
rs7628950; Suicide attempts in bipolar disorder; bipolar disorder
rs10510834; Bipolar disorder; bipolar disorder
rs10510834; Suicide attempts in bipolar disorder; bipolar disorder
rs9311754; Bipolar disorder; bipolar disorder
rs13082004; Suicide attempts in bipolar disorder; bipolar disorder
rs17062579; Insulin resistance; type 2 diabetes mellitus
rs17062609; Insulin resistance; type 2 diabetes mellitus
rs143018; Lung function (forced expiratory volume in 1 second); lung disease
rs10510835; Sleep and circadian phenotypes; sleep disorder
rs10510835; Cognitive test performance; cognitive disorder
rs213333; Lung function (forced expiratory volume in 1 second); lung disease
rs213344; Type 2 diabetes and 6 quantitative traits; type 2 diabetes mellitus
rs9879860; Coronary restenosis; coronary artery disease
rs6768755; Height; Null
rs9829607; Coronary restenosis; coronary artery disease
rs10510837; Asperger disorder; Asperger syndrome
rs1353546; Coronary restenosis; coronary artery disease
rs6776005; Kawasaki disease; Kawasaki disease
rs7631389; Coronary restenosis; coronary artery disease
rs7647196; Multiple complex diseases; Null
rs963685; Suicide attempts in bipolar disorder; bipolar disorder
rs11708562; Smoking quantity; nicotine dependence
rs17062850; Response to cytidine analogues (gemcitabine); cancer
rs1057504; Cognitive impairment induced by topiramate; cognitive disorder
rs11130770; Aortic root size; cardiovascular system disease
rs4679533; Aortic root size; cardiovascular system disease
rs9848065; Urinary metabolites; kidney disease
rs17062963; Urinary metabolites; kidney disease
rs13098396; Urinary metabolites; kidney disease
rs242201; Kawasaki disease; Kawasaki disease
rs242201; Lipid levels; lipid metabolism disorder|cardiovascular system disease|obesity
rs2687194; Glycemic traits (pregnancy); type 2 diabetes mellitus
rs409484; Urinary metabolites; kidney disease
rs4566489; Lung function (forced expiratory volume in 1 second); lung disease
rs12629710; Type 2 diabetes; type 2 diabetes mellitus
rs12638086; Type 2 diabetes; type 2 diabetes mellitus
rs12638610; Type 2 diabetes; type 2 diabetes mellitus
rs1579912; Type 2 diabetes; type 2 diabetes mellitus
rs424675; Type 2 diabetes; type 2 diabetes mellitus
rs378346; Type 2 diabetes; type 2 diabetes mellitus
rs2594239; Multiple complex diseases; Null
rs1447971; Sleep time; sleep disorder
rs2205042; Sleep latency; sleep disorder
rs2594266; Multiple complex diseases; Null
rs9985430; Urinary metabolites; kidney disease
rs6789538; Lung function (forced vital capacity); lung disease
rs10212340; Multiple complex diseases; Null
rs10212340; Urinary metabolites; kidney disease
rs80171647; Response to amphetamines; amphetamine abuse
rs12492175; White matter integrity; bipolar disorder|brain disease
rs12492175; Alzheimer's disease; Alzheimer's disease
rs241704; Prostate cancer; prostate cancer
rs7426703; Response to amphetamines; amphetamine abuse
rs17063477; Response to amphetamines; amphetamine abuse
rs11130772; Lung function (forced expiratory volume in 1 second); lung disease
rs241684; Bipolar disorder and schizophrenia; bipolar disorder|schizophrenia
rs76200451; Response to amphetamines; amphetamine abuse
rs151737; White matter integrity; bipolar disorder|brain disease
rs2856045; Bipolar disorder and schizophrenia; bipolar disorder|schizophrenia
rs180998; Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption); hypertension
rs17063532; Vaspin levels; obesity|type 2 diabetes mellitus
rs17063532; Treatment outcomes for selective serotonin reuptake inhibitors (SSRIs) - response at 8 weeks; major depressive disorder
rs2734365; Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months); rheumatoid arthritis
rs2734365; Methotrexate clearance (acute lymphoblastic leukemia); acute lymphocytic leukemia|acute leukemia
rs10510850; Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption); hypertension
rs9833533; Response to cytadine analogues (cytosine arabinoside); cancer
rs7651468; Response to cytadine analogues (cytosine arabinoside); cancer
rs2252742; Type 2 diabetes; type 2 diabetes mellitus
rs7617530; Anxiety spectrum disorders; panic disorder
rs2856030; Urinary metabolites; kidney disease
rs11720214; Alzheimer's disease (late onset); Alzheimer's disease
rs11720214; Lung function (forced expiratory flow between 25% and 75% of forced vital capacity); lung disease
rs17624325; Smoking cessation; nicotine dependence
rs2885865; Prostate cancer mortality; prostate cancer
rs11926787; Smoking initiation; nicotine dependence
rs6762641; Urinary metabolites; kidney disease
rs10510852; Rheumatoid arthritis; rheumatoid arthritis
rs10510853; Paclitaxel sensitivity in NCI60 cancer cell lines; breast cancer|ovarian cancer
rs1623091; Body mass index; obesity
rs1735444; Parkinson's disease; Parkinson's disease
rs1735457; Alcohol dependence; alcohol dependence
rs1735460; Alcohol dependence; alcohol dependence
rs1735460; Alcoholism; alcohol dependence
rs1716744; Aortic root size; cardiovascular system disease
rs12493219; Erythrocyte counts; hematopoietic system disease|heart disease
rs12631593; Alzheimer's disease (late onset); Alzheimer's disease
rs4974227; Alzheimer's disease; Alzheimer's disease
rs1569346; Lung function (forced expiratory flow between 25% and 75% of forced vital capacity); lung disease
rs13073028; Cognitive test performance; cognitive disorder
rs11919041; Breast size; breast cancer
rs12492901; Alzheimer's disease; Alzheimer's disease
rs6791644; Attention deficit hyperactivity disorder; attention deficit hyperactivity disorder
rs4974230; Pericardial fat; myocardial infarction
rs1447927; Alzheimer's disease; Alzheimer's disease
rs17064028; Urinary metabolites; kidney disease
rs2142296; Urinary metabolites; kidney disease
rs17064029; Fibrinogen; cardiovascular system disease
rs2364295; Urinary metabolites; kidney disease
rs2205353; Response to cytidine analogues (gemcitabine); cancer
rs2594135; Multiple complex diseases; Null
rs2594135; Urinary metabolites; kidney disease
rs17064083; Alcohol dependence; alcohol dependence
rs17064094; Multiple complex diseases; Null
rs7613542; Sarcoidosis; sarcoidosis
rs2121845; Urinary metabolites; kidney disease
rs1562524; Response to statin therapy; coronary artery disease|myopathy|atherosclerosis
rs6792544; Urinary metabolites; kidney disease
rs6782531; Blood pressure; hypertension
rs6786392; Height; Null
rs2365045; Multiple sclerosis; multiple sclerosis
rs1898748; Multiple complex diseases; Null
rs17064337; Multiple complex diseases; Null
rs11715589; Multiple complex diseases; Null
rs11715589; Alzheimer's disease; Alzheimer's disease
rs17064395; Lung function (forced expiratory flow between 25% and 75% of forced vital capacity); lung disease
rs7650123; Alzheimer's disease; Alzheimer's disease
rs9850713; Alzheimer's disease; Alzheimer's disease
rs1965143; Alzheimer's disease; Alzheimer's disease
rs10222378; Alzheimer's disease; Alzheimer's disease
rs9855931; Alzheimer's disease; Alzheimer's disease
rs7631974; Alzheimer's disease; Alzheimer's disease
rs11919495; Alzheimer's disease; Alzheimer's disease
rs9871875; Alzheimer's disease; Alzheimer's disease
rs9834182; Alzheimer's disease; Alzheimer's disease
rs9876579; Alzheimer's disease; Alzheimer's disease
rs9845837; Major depressive disorder; major depressive disorder
rs17687542; Coronary heart disease; coronary artery disease
rs1347852; Major depressive disorder; major depressive disorder
rs11921290; Coronary heart disease; coronary artery disease
rs9825823; Alcohol dependence; alcohol dependence
rs9825823; Major depressive disorder; major depressive disorder
rs9825823; Alcoholism; alcohol dependence
rs7626688; Multiple complex diseases; Null
rs7626688; Major depressive disorder; major depressive disorder
rs6445194; Alcohol dependence; alcohol dependence
rs6445194; Major depressive disorder; major depressive disorder
rs6445194; Depression (quantitative trait); mental depression
rs1821942; Heart Failure; congestive heart failure
rs9830950; Major depressive disorder; major depressive disorder
rs2886261; Salmonella-induced pyroptosis; Null
rs9877396; Bronchopulmonary dysplasia; bronchopulmonary dysplasia
rs4309721; Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption); hypertension
rs4309721; Major depressive disorder; major depressive disorder
rs6807748; Major depressive disorder; major depressive disorder
rs11707984; Major depressive disorder; major depressive disorder
rs1966136; Major depressive disorder; major depressive disorder
rs4020068; Major depressive disorder; major depressive disorder
rs9851485; Major depressive disorder; major depressive disorder
rs9871451; Major depressive disorder; major depressive disorder
rs1969420; Major depressive disorder; major depressive disorder
rs1550343; Major depressive disorder; major depressive disorder
rs7631246; Major depressive disorder; major depressive disorder
rs9875365; Suicidal ideation; major depressive disorder
rs9875228; Multiple complex diseases; Null
rs1001788; Tourette syndrome; Gilles de la Tourette syndrome|obsessive-compulsive disorder|attention deficit hyperactivity disorder
rs9846073; Major depressive disorder; major depressive disorder
rs1916800; Major depressive disorder; major depressive disorder
rs9843007; Major depressive disorder; major depressive disorder
rs6802718; Left ventricular hypertrophy; hypertrophic cardiomyopathy